The crowdsourcing platform, backed by CyberAgent, Digital Garage, Dentsu and Itochu, has secured about $14.5m in funding since it was founded in 2011.

The solar power provider slashed its initial public offering from $150m to $55.2m after suspending it citing market conditions.

SolarBridge, backed by corporate venturing units Constellation Technology Ventures and Shea Ventures, had raised over $100m in venture funding.

The biosimilar developer, backed by Eli Lilly, Daaichi Sankyo and Medpace, will use the proceeds from its initial public offering to advance three of its product candidates.

Shareholders Novo and Johnson & Johnson invested a total of $4.6m as the neurostimulation device maker went public in a flotation that could rise to almost $145m.

The MedImmune-backed glaucoma treatment developer aims to raise up to $86.3m from its initial public offering, as well as an additional $46m in convertible debt.

Biopharmaceutical spin-out F-Star Alpha and Bristol-Myers Squibb sign acquisition agreement for $50m.

AbbbVie-backed Virobay had planned to raise up to $50m in an initial public offering that would have funded development of its drug development programme.

SheKnows has acquired its competitor BlogHer for between $30m and $40m in a deal that will give an exit to NBC and GE-backed firm Peacock Equity.